Mid-day market update: Dow gains 100 points; Rubius Therapeutics (RUBY Stock) shares plummet
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERMidway through trading Wednesday, the Dow traded up 0.32% to 32,930.37while the NASDAQ fell 1.08% to 13,325.62. The S&P also fell, dropping 0.39% to 3,947.09.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,549,550 cases with around 536,920 deaths. Brazil reported over 11,603,530 COVID-19 cases with 282,120 deaths, while India confirmed a total of at least 11,438,730 cases and 159,040 deaths. In total, there were at least 120,791,360 cases of COVID-19 worldwide with more than 2,672,480 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Industrials shares rose 0.9% on Wednesday. Meanwhile, top gainers in the sector included Willis Lease Finance Corporation WLFC 27.38%, up 25%, and Navios Maritime Holdings Inc. NM 27.25%, up 17%.
In trading on Wednesday, information technology shares fell 1.2%.
Top Headline
Cintas Corporation CTAS 2.59% reported better-than-expected results for its third quarter.
Cintas posted quarterly earnings of $2.37 per share, beating analysts’ estimates of $2.21 per share. The company’s quarterly sales came in at $1.78 billion, exceeding expectations of $1.75 billion.
Cintas said it expects Q4 EPS of $2.20-$2.40 versus analysts’ estimates of $2.18. The company projects sales of $1.8 billion-$1.83 billion.
Equities Trading UP
Immatics N.V. IMTX 27.73% shares shot up 30% to $15.10 after the company announced a clinical data update from the dose escalation cohorts of the company's ongoing Phase 1 trials for its engineered Adoptive Cell Therapy.
Shares of FSD Pharma Inc. HUGE 15.46% got a boost, shooting 13% to $2.33 as the company entered into a license agreement to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats..
Mistras Group, Inc. MG 14.59% shares were also up, gaining 13% to $11.80 after the company reported-better-than-expected Q4 results.
Check out these big movers of the day
Equities Trading DOWN
IMV Inc. IMV 18.72% shares tumbled 17% to $3.24 after the company reported a wider FY20 loss.
Shares of Rubius Therapeutics, Inc. RUBY 17.95% were down 18% to $26.32 after the company priced its 6.9 million share common stock at $29 per share. Rubius Therapeutics recently reported initial data from its ongoing Phase 1/2 trial of RTX-240 in patients with advanced solid tumors.
South Jersey Industries, Inc. SJI 16.39% was down, falling 17% to $23.08 after the company announced a $225 million common stock and equity units offering.
Commodities
In commodity news, oil traded down 0.9% to $64.22, while gold traded down 0.3% to $1,725.20.
Silver traded down 0.1% Wednesday to $25.97 while copper rose 1.1% to $4.1180.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 fell 0.45%, the Spanish Ibex Index fell 0.69% and the German DAX 30 gained 0.18%. Meanwhile, the French CAC 40 rose 0.06%, London’s FTSE 100 fell 0.51% and Italy’s FTSE MIB rose 0.04%.
Demand for new passenger cars in the European Union dipped 19.3% annually to 771,486 units in February.
Economics
Housing starts dropped 10.3% to an annualized rate of 1.421 million in February, while building permits dipped 10.8% to an annual rate of 1.682 million in February.
US crude oil inventories increased 2.396 million barrels fir the week ended March 12, following a 13.798-million rise in the previous week, the Energy Information Administration said.
The Federal Reserve will announce its policy decision at 2:00 p.m. ET.
The Fed Chairman Jerome Powell will hold a press conference at 2:30 p.m. ET.
Midway through trading Wednesday, the Dow traded up 0.32% to 32,930.37while the NASDAQ fell 1.08% to 13,325.62. The S&P also fell, dropping 0.39% to 3,947.09.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,549,550 cases with around 536,920 deaths. Brazil reported over 11,603,530 COVID-19 cases with 282,120 deaths, while India confirmed a total of at least 11,438,730 cases and 159,040 deaths. In total, there were at least 120,791,360 cases of COVID-19 worldwide with more than 2,672,480 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Industrials shares rose 0.9% on Wednesday. Meanwhile, top gainers in the sector included Willis Lease Finance Corporation WLFC 27.38%, up 25%, and Navios Maritime Holdings Inc. NM 27.25%, up 17%.
In trading on Wednesday, information technology shares fell 1.2%.
Top Headline
Cintas Corporation CTAS 2.59% reported better-than-expected results for its third quarter.
Cintas posted quarterly earnings of $2.37 per share, beating analysts’ estimates of $2.21 per share. The company’s quarterly sales came in at $1.78 billion, exceeding expectations of $1.75 billion.
Cintas said it expects Q4 EPS of $2.20-$2.40 versus analysts’ estimates of $2.18. The company projects sales of $1.8 billion-$1.83 billion.
Equities Trading UP
Immatics N.V. IMTX 27.73% shares shot up 30% to $15.10 after the company announced a clinical data update from the dose escalation cohorts of the company's ongoing Phase 1 trials for its engineered Adoptive Cell Therapy.
Shares of FSD Pharma Inc. HUGE 15.46% got a boost, shooting 13% to $2.33 as the company entered into a license agreement to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats..
Mistras Group, Inc. MG 14.59% shares were also up, gaining 13% to $11.80 after the company reported-better-than-expected Q4 results.
Check out these big movers of the day
Equities Trading DOWN
IMV Inc. IMV 18.72% shares tumbled 17% to $3.24 after the company reported a wider FY20 loss.
Shares of Rubius Therapeutics, Inc. RUBY 17.95% were down 18% to $26.32 after the company priced its 6.9 million share common stock at $29 per share. Rubius Therapeutics recently reported initial data from its ongoing Phase 1/2 trial of RTX-240 in patients with advanced solid tumors.
South Jersey Industries, Inc. SJI 16.39% was down, falling 17% to $23.08 after the company announced a $225 million common stock and equity units offering.
Commodities
In commodity news, oil traded down 0.9% to $64.22, while gold traded down 0.3% to $1,725.20.
Silver traded down 0.1% Wednesday to $25.97 while copper rose 1.1% to $4.1180.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 fell 0.45%, the Spanish Ibex Index fell 0.69% and the German DAX 30 gained 0.18%. Meanwhile, the French CAC 40 rose 0.06%, London’s FTSE 100 fell 0.51% and Italy’s FTSE MIB rose 0.04%.
Demand for new passenger cars in the European Union dipped 19.3% annually to 771,486 units in February.
Economics
Housing starts dropped 10.3% to an annualized rate of 1.421 million in February, while building permits dipped 10.8% to an annual rate of 1.682 million in February.
US crude oil inventories increased 2.396 million barrels fir the week ended March 12, following a 13.798-million rise in the previous week, the Energy Information Administration said.
The Federal Reserve will announce its policy decision at 2:00 p.m. ET.
The Fed Chairman Jerome Powell will hold a press conference at 2:30 p.m. ET.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.